Showing 4971-4980 of 20470 results for "".
- Contrast Media in Hospitalized Patients with AKI: Renal and Clinical Outcomeshttps://reachmd.com/news/contrast-media-in-hospitalized-patients-with-aki-renal-and-clinical-outcomes/2485925/Hospital teams often weigh diagnostic yield against renal risk when considering iodinated contrast in patients with acute kidney injury (AKI). In
- Endo‑DCR Research Trends in Asia: Bibliometric Findingshttps://reachmd.com/news/endodcr-research-trends-in-asia-bibliometric-findings/2485935/A SCOPUS-based bibliometric approach was used to examine Endoscopic dacryocystorhinostomy (Endo-DCR) research in Asian countries, summarizing publication trends alongside country contributions and keyword co-occurrence patterns. Using SCOPUS-indexed Endo-DCR publicat
- Avidity's Planned MDA 2026 Presentationshttps://reachmd.com/news/aviditys-planned-mda-2026-presentations-programs-data-types-and-session-formats/2485906/Avidity Biosciences’ press release outlines its planned presence at the
- CHILL Trial Launch: Quell’s QEL‑005 CAR‑Treg Enters Phase 1/2https://reachmd.com/news/chill-trial-launch-quells-qel005-cartreg-enters-phase-12/2485897/Quell Therapeutics said in a company press release that it has initiated the
- FDA Accepts Brepocitinib NDA; Priority Review Assigned for Dermatomyositishttps://reachmd.com/news/fda-accepts-brepocitinib-nda-priority-review-assigned-for-dermatomyositis/2485898/Priovant Therapeutics reported that the FDA has accepted its New Drug Application for
- ADVANCE OUTCOMES: United Therapeutics Reports 55% Risk Reduction with Ralinepaghttps://reachmd.com/news/advance-outcomes-united-therapeutics-reports-55-risk-reduction-with-ralinepag/2485895/United Therapeutics reported in its ADVANCE OUTCOMES release that the long-term pivotal phase 3 ADVANCE OUTCOMES trial of the oral prostacyclin (IP) receptor agonist ralin
- Real-World Patterns in Peyronie’s Diseasehttps://reachmd.com/news/real-world-patterns-in-peyronies-disease/2485876/Peyronie’s disease remains one of the more undercharacterized conditions in men’s health, despite its significant impact on sexual function and quality of life. While clinical trials and specialty center reports
- Ocular‑Motor Testing Detects Persistent Changes After Mild TBI in Veteranshttps://reachmd.com/news/ocularmotor-testing-detects-persistent-changes-after-mild-tbi-in-veterans/2485899/Veterans with a history of mild traumatic brain injury were described as more likely than those without such a history
- Low‑dose Lithium and Verbal Memory in MCIhttps://reachmd.com/news/low-dose-lithium-mci/2485882/In a JAMA Neurology study, low-dose oral lithium was compared with placebo over two years in older adults with mild cognitive impairment (MCI), with an explora
- Belzutifan + Pembrolizumab and Post‑Nephrectomy Recurrence in ccRCChttps://reachmd.com/news/belzutifan-pembrolizumab-postnephrectomy-ccrcc/2485886/Phase 3 results in high-risk clear cell renal cell carcinoma (ccRCC) after surgery were reported as showing a lower risk of recurrence and improved disease-free survival with a two-drug adjuvant approach. In